Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

This study is testing a new drug called LM-108, given alongside an immunotherapy drug and two standard chemotherapy drugs, for people with advanced pancreatic cancer that cannot be removed by surgery. The main goals are to see if this combination is safe and if it can help contro…

This study is testing whether a new injection called TQH2929 can safely and effectively treat sudden, severe flare-ups of generalized pustular psoriasis, a painful skin disease. It will involve 36 adults who are currently experiencing a flare-up. Participants will receive either …

This study is testing a new inhaled powder called TQC3721 for people with moderate to severe chronic obstructive pulmonary disease (COPD). About 195 participants will use the inhaler or a placebo for 4 weeks to see if it improves their lung function and quality of life. The main …

This study is testing a new drug called Rovadicitinib for people with moderate-to-severe chronic graft-versus-host disease (cGVHD) who have already tried at least two other treatments. It aims to see if Rovadicitinib is better than other standard treatments at reducing symptoms a…

This study is testing whether a new capsule called AL2846 can help control advanced thyroid cancer that has stopped responding to standard treatments. It will compare AL2846 against a placebo in 144 adults whose cancer has progressed despite previous therapy. The main goal is to …

This study is testing a new drug, TQB2825, combined with standard chemotherapy for people with diffuse large B-cell lymphoma, a fast-growing blood cancer. It aims to see if the combination is safe and more effective at controlling the disease, especially for patients who are newl…

This study is testing a combination of two new drugs, TQ05105 and TQB3617, for people with intermediate- or high-risk myelofibrosis, a rare bone marrow cancer. The main goals are to find the safest and most effective dose and to see if the treatment can shrink enlarged spleens an…

This study is testing the long-term safety and effectiveness of an investigational injection called TQH2722 for people with severe chronic sinusitis, with or without nasal polyps. It will involve about 120 adults who previously took part in an earlier study of the same drug. Rese…

This is the first time researchers are testing the experimental drug TQB3122 in people. The study aims to find the safest dose and check for side effects in 86 adults with advanced cancers that have stopped responding to standard treatments. Researchers will also gather early inf…

This is the first study in people to test the safety and side effects of a new oral medication called TQB3019 for advanced cancers. Researchers will give the capsules to about 80 adults with advanced cancer to find the safest and most tolerable dose. The main goals are to underst…

This is the first human study testing a new diabetes medication called TQF3250 capsules. Researchers will give the drug to 66 healthy adults to check its safety, how the body processes it, and what side effects might occur. The goal is to see if this new type of medication could …

This clinical trial is testing an experimental drug called TQB6411 injection for people with advanced esophageal cancer that has returned or spread. The study aims to find the safest dose and see if the drug can help control the cancer in patients whose previous treatments with i…

This is a first-in-human study to test the safety and find the right dose of a new drug called TQB3002 for people with advanced cancers. It is for adults whose cancer has continued to grow despite standard treatments or who have no other effective options. The main goals are to s…